Beal MF, Mazurek MF, Tran VT, Chattha G, Bird ED, Martin JB (1985)
Reduced numbers of somatostatin receptors in the cerebral cortex
in Alzheimer's disease. Science 229:289 –291.
Bell GI, Reisine T (1993) Molecular biology of somatostatin receptors.
Trends Neurosci 16:34 –38.
Bergström L, Garlind A, Nilsson L, Alafuzoff I, Fowler CJ, Windblad B,
Cowburn RF (1991) Regional distribution of somatostatin binding
and modulation of adenylyl cyclase activity in Alzheimer's disease
brain. J Neurol Sci 105:225–233.
Buchet R, Tavitian E, Ristig D, Swoboda R, Stauss U, Gremlich HU,
De La Fournier L, Staufienbiel M, Frey P, Lowe DA (1996) Conformations of synthetic beta peptides in solid state and in aqueous
solution: relation to toxicity in PC12 cells. Biochim Biophys Acta
1315:40 – 46.
Cacabelos R, Niigawa H, Rodríguez-Arnao MD, Gomez-Pan A,
Nishimura T (1988) Influence of somatostatin and growth hormone-releasing factor on behaviour. Horm Res 29:129 –132.
Cagnin A, Brooks DJ, Kennedy AM, Gunn RN, Myers R, Turkheimer
FE, Jones T, Banati RB (2001) In-vivo measurement of activated
microglia in dementia. Lancet 358:461– 467.
Cowburn RF, Fowler CJ, Garlind A, Alafozoff O, Nilsson L, Winblad B,
Bergström L (1991) Somatostatin receptors and the modulation of
adenylyl cyclase activity in Alzheimer's disease. J Neurol Neurosurg Psychiatry 54:748 –749.
Cowburn RF, Fowler CJ, O'Neill C (1996) Neurotransmitters, signal
transduction and second-messengers in Alzheimer's disease. Acta
Neurol Scand 165:25–32.
Cowburn RF, O'Neill C, Ravid R, Winblad B, Fowler CJ (1992) Preservation of Gi-protein inhibited adenylyl cyclase activity in the
brains of patients with Alzheimer's disease. Neurosci Lett
141:16 –20.
Cowburn RF, Wiehager B, Trief E, Li-Li M, Sundstrom E (1997) Effects
of beta-amyloid-(25–35) peptides on radioligand binding to excitatory amino acid receptors and voltage-dependent calcium
channels: evidence for a selective affinity for the glutamate and
glycine recognition sites of the NMDA receptor. Neurochem Res
22:1437_1442.
Czernik AJ, Petrack V (1983) Somatostatin receptor binding in the rat
cerebral cortex. Characterization using a nonreducible somatostatin analog. J Biol Chem 285:5525–5530.
Davies P, Katzman R, Terry RD (1980) Reduced somatostatin-like
immunoreactivity in cerebral cortex from cases of Alzheimer's disease and Alzheimer senile dementia. Nature 288:279 –280.
Dournaud P, Cervera-Pierrot P, Hirsch E, Javoy-Agid F, Kordon C,
Agid Y, Epelbaum J (1994) Somatostatin mRNA-containing neurons in Alzheimer's disease: an in situ hybridization study in hippocampus, parahippocampal cortex and frontal cortex. Neuroscience 61:755–764.
Dournaud P, Jazat-Poindessous F, Slama A, Lamour Y, Epelbaum J
(1996) Correlations between water maze performance and cortical
somatostatin mRNA and high-affinity binding sites during ageing in
rats. Eur J Pharmacol 8:476 – 485.
Epelbaum J, Tapia-Arancibia L, Cordón C, Enjalbert A (1982) Characterization, regional distribution and subcellular distribution of
125I-Tyr11-somatostatin binding sites in rat brain. J Neurochem
38:1515–1523.
Epelbaum J (1986) Somatostatin in the central nervous system: physiology and pathological modifications. Prog Neurobiol 27:63–100.
Feindt J, Becker I, Blomer U, Hugo HH, Mehdorn HM, Krisch B,
Mentlein R (1995) Expression of somatostatin receptor subtypes in
cultured astrocytes and gliomas. J Neurochem 65:1997–2005.
Feindt J, Schmidt A, Mentlein R (1998) Receptors and effects of the
inhibitory neuropeptide somatostatin in microglial cells. Brain Res
Mol Brain Res 60:228 –233.
Garlind A, Fowler CJ, Alafuzoff I, Winbland B, Cowburn RF (1992)
Neurotransmitter-mediated inhibition of post-mortem human brain
adenylyl cyclase. J Neural Transm Gen Sect 87:113–124.
